Walvax Biotechnology Co., Ltd. announced that at its AGM held on 12 April 2022, the shareholders approved the 2021 profit distribution plan as cash dividend/10 shares (tax included): CNY 0.27000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.71 CNY | -0.88% | +2.65% | -37.43% |
04-26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
04-25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.43% | 3.25B | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-15.94% | 31.09B | |
+52.66% | 24.74B | |
-14.50% | 15.91B | |
-9.12% | 11.96B | |
-14.38% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Co., Ltd. Approves Cash Dividend for 2021